EQS-News: Medacta Group SA: Medacta Adds the MyHip Planner and the MyHip Verifier Tools to its Personalized Medicine Solutions for Hip Replacement
(R) Verifier Tools to its Personalized Medicine Solutions for Hip Replacement
CASTEL SAN PIETRO,
15 February 2021 - Medacta is proud to announce that it has received clearance from the U.S. Food and Drug Administration (FDA) for its MyHip
(R) Planner and MyHip
(R) Verifier, after recently receiving CE marking and approval from Australia s Therapeutic Goods Administration (TGA) and from the Japanese Ministry of Health, Labour and Welfare (MHLW). These two promising innovative technologies will be introduced into all markets in which Medacta operates in the upcoming months.
У Японії схвалили першу вакцину від коронавірусу: яким препаратом і коли почнуть щеплювати людей
tsn.ua - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tsn.ua Daily Mail and Mail on Sunday newspapers.
🠴 DIRECT - Coronavirus : l Union européenne va autoriser plus rapidement les vaccins contre les variants
cnews.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cnews.fr Daily Mail and Mail on Sunday newspapers.
Le Japon autorise l utilisation du vaccin Pfizer
latribune.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from latribune.fr Daily Mail and Mail on Sunday newspapers.